Analgesic nephropathy Belgium

In Belgium, the distribution of analgesic nephropathy in patients with terminal renal insufficiency was well correlated with the sale of drugs containing either aspirin -I- phenacetin or paracetamol + caffeine (SEDA-7,75), and it is estimated that Belgium, after Australia, had the second highest incidence of analgesic nephropathy in the world. 

Figure 2. Incidence of analgesic nephropathy (AN) in Australia 1971-2005. B. Incidence of AN in Belgium 1970-1998 and in Flanders 1994-2006. At the bottom, absolute numbers of new AN.

Elseviers MM, De Broe ME. Is analgesic nephropathy still a problem in Belgium Nephrol Dial Transplant 1988 2 143-149. Matyus J, Ujhelyi L, Karpati I, BenT, KakukG. Increase in the incidence of analgesic nephropathy in Hungary. Nephrol Dial Transplant 1997 12(8) 1774-1775. 

Vanherweghem JL, Even-Adin D. Epidemiology of analgesic nephropathy in Belgium. Clin Nephrol 1982 17 129-133. 

Noels LM, Elseviers MM, De Broe ME. Impact of legislative measures on the sales of analgesics and the subsequent prevalenceof analgesic nephropathy a comparative study in France, Sweden and Belgium. Nephrol Dial Transplant 1995 10 167-174. Primary renal disease. ANZDATA Registry 2000 Report. 

Elsevlers MM, De Broe ME. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures. Nephrol Dial Transplant 1994 9 41-46. 

---